Tim-3 expression on peripheral monocytes and CD3+CD16/CD56+natural killer-like T cells in patients with chronic hepatitis B

Tissue Antigens

Volumn 83, Issue 2, 2014, Pages 76-81

  Rong, Y H ^a,b   Wan, Z H ^b   Song, H ^c   Li, Y L ^b   Zhu, B ^b   Zang, H ^b   Zhao, Y ^d   Liu, H L ^b   Zhang, A M ^b   Xiao, L ^b   Xin, S J ^b   You, S L ^b  

^a MEDICAL SCHOOL OF CHINESE PLA   (China)

^b BEIJING 302 HOSPITAL   (China)

^c Division of Obstetrics and Gynecology   (Canada)

^d Liver Diseases Center   (China)

Author keywords

Acute on chronic liver failure; Chronic hepatitis B; Monocyte; Natural killer like T cell; Tim 3

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; MEMBRANE PROTEIN; TIM 3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; FLOW CYTOMETRY; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NATURAL KILLER T CELL; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UPREGULATION;

HEPATITIS B VIRUS;

ACUTE-ON-CHRONIC LIVER FAILURE; CHRONIC HEPATITIS B; MONOCYTE; NATURAL KILLER-LIKE T CELL; TIM-3;

ADULT; ALANINE TRANSAMINASE; ANTIGENS, CD3; ANTIGENS, CD56; CASE-CONTROL STUDIES; END STAGE LIVER DISEASE; FEMALE; GENE EXPRESSION; GPI-LINKED PROTEINS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; LIVER FAILURE, ACUTE; MALE; MEMBRANE PROTEINS; MONOCYTES; RECEPTORS, IGG; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892984045     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12278     Document Type: Article

References (21)

1. Tan YJ. Hepatitis B virus infection and the risk of hepatocellular carcinoma. World J Gastroenterol 2011: 17: 4853-7.
2. Gish R, Jia JD, Locarnini S, Zoulim F. Selection of chronic hepatitis B therapy with high barrier to resistance. Lancet Infect Dis 2012: 12: 341-53.
3. Olson JC, Kamath PS. Acute-on-chronic liver failure: what are the implications? Curr Gastroenterol Rep 2012: 14: 63-6.
4. Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011: 11: 762-74.
5. Trippler M, Meyer Zum Buschenfelde KH, Gerken G. HBV viral load within sub-populations of peripheral blood mononuclear cells in HBV infection using limiting dilution PCR. J Virol Methods 1999: 78: 129-47.
6. Yoffe B, Noonan CA, Melnick JL, Hollinger FB. Hepatitis B virus DNA in mononuclear cells and analysis of cell subsets for the presence of replicative intermediates of viral DNA. J Infect Dis 1986: 153: 471-7.
7. Pratschke J, Stauch D, Kotsch K. Role of NK and NKT cells in solid organ transplantation. Transpl Int 2009: 22: 859-68.
8. Uemura Y, Suzuki M, Liu TY et al. Role of human non-invariant NKT lymphocytes in the maintenance of type 2T helper environment during pregnancy. Int Immunol 2008: 20: 405-12.
9. Zhou J, Zhao X, Wang Z, Wang J, Sun H, Hu Y. High circulating CD3+CD56+CD16+ natural killer-like T cell levels predict a better IVF treatment outcome. J Reprod Immunol 2013: 97: 197-203.
10. Bojarska-Junak A, Hus I, Sieklucka M et al. Natural killer-like T CD3+/CD16+CD56+ cells in chronic lymphocytic leukemia: intracellular cytokine expression and relationship with clinical outcome. Oncol Rep 2010: 24: 803-10.
11. Sánchez-Fueyo A, Tian J, Picarella D et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 2003: 4: 1093-101.
12. Elahi S, Niki T, Hirashima M, Horton H. Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection. Blood 2012: 119: 4192-204.
13. Moorman JP, Wang JM, Zhang Y et al. Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection. J Immunol 2012: 189: 755-66.
14. Jin HT, Anderson AC, Tan WG et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A 2010: 107: 14733-8.
15. Wu W, Shi Y, Li J, Chen F, Chen Z, Zheng M. Tim-3 expression on peripheral T cell subsets correlates with disease progression in hepatitis B infection. Virol J 2011: 8: 113.
16. Li H, Wu K, Tao K et al. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma. Hepatology 2012: 56: 1342-51.
17. Cao D, Xu H, Guo G et al. Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure. Inflammation 2013: 36: 110-20.
18. Yang ZZ, Grote DM, Ziesmer SC et al. IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma. J Clin Invest 2012: 122: 1271-82.
19. Sun X, Qin W, Zhou R, Wang L, Li Y, Zhao L. Effect of conventional interferon-α in patients with HBeAg-positive chronic hepatitis B: a systematic review and meta-analysis. J Evid Based Med 2010: 3: 220-5.
20. Lee YH, Bae SC, Song GG. Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy. Clin Exp Rheumatol 2013: 31: 118-21.
21. Nathan DM, Angus PW, Gibson PR. Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approach. J Gastroenterol Hepatol 2006: 21: 1366-71.